Seastar Medical Holding Corp (ICU) - Form 8-K Summary
Business Context and Reporting Period
Seastar Medical Holding Corporation, an emerging growth company incorporated in Delaware, filed this Current Report on August 13, 2025. The filing announces the financial condition and results of operations for the three and six months ended June 30, 2025. The company's common stock and warrants trade on The Nasdaq Stock Market LLC under the symbols ICU and ICUCW, respectively.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K serves as a notification that a press release containing these details has been issued. The specific financial data is contained within Exhibit 99.1 (Press Release dated August 13, 2025), which is furnished but not included in the text of this summary.
Material Changes
No material changes versus prior periods are detailed in the provided text. The document references a press release for the comparative analysis of the three and six months ended June 30, 2025.
Guidance, Outlook, and Risks
The filing does not contain specific management commentary, forward-looking guidance, or a discussion of risks and contingencies within the main body text. These elements are referenced as being part of the furnished press release (Exhibit 99.1). The filing explicitly states that the information is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, limiting liability and incorporation by reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the periods ended June 30, 2025.
- Verify the company's liquidity position and debt obligations as detailed in the press release.
- Check for any updated financial guidance or operational outlook provided in the August 13, 2025 announcement.
- Confirm the status of the warrants (ICUCW) and their exercise price of $11.50 per share.